• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Statson Pharmaceuticals Establishes New Brand, KC Specialty Therapeutics, In Kansas City, Kansas

Stason Pharmaceuticals, Inc. is moving its brand division from Irvine, California to Kansas City, Kansas. The firm said it will establish a new entity, KC Specialty Therapeutics, to focus on research and development of new chemical entities for humans.

KC Specialty Therapeutics LLC will locate alongside Statson’s Animal Health at the Bioscience & Technology Business Center located on the University of Kansas Medical Center campus. Over the next year, the company will create job opportunities in Kansas City and continue to grow its presence over time.

"Stason Pharmaceuticals has been very impressed with the biosciences opportunities in the Kansas City region since moving Stason Animal Health's national headquarters here earlier this year," said Diana Wood, Vice President of corporate development for Stason Pharmaceuticals and CEO for KC Specialty Therapeutics LLC. "The KC Animal Health Corridor and broader life sciences community have been incredibly supportive."

Today's announcement comes just 90 days after Stason Pharmaceutical's animal division, Stason Animal Health, announced it was relocating its corporate headquarters to the KC Animal Health Corridor.

"We are thrilled that Stason Pharmaceuticals values our region's strong biosciences business environment," said Bob Marcusse, President and CEO, Kansas City Area Development Council. "We look forward to seeing both Stason Pharmaceuticals and KC Specialty Therapeutics grow in our region."

Exclusive Research